Pyrazolo [3, 4-c] pyridazines as novel and selective inhibitors of cyclin-dependent kinases

…, F Llinares, D Munoz-Mingarro, O Lozach…

Index: Brana, Miguel F.; Cacho, Monica; Garcia, M. Luisa; Mayoral, Elena P.; Lopez, Berta; De Pascual-Teresa, Beatriz; Ramos, Ana; Acero, Nuria; Llinares, Francisco; Munoz-Mingarro, Dolores; Lozach, Olivier; Meijer, Laurent Journal of Medicinal Chemistry, 2005 , vol. 48, # 22 p. 6843 - 6854

Full Text: HTML

Citation Number: 67

Abstract

Pyrazolopyridazine 1a was identified in a high-throughput screening carried out by BASF Bioresearch Corp.(Worcester, MA) as a potent inhibitor of CDK1/cyclin B and shown to have selectivity for the CDK family. Analogues of the lead compound have been synthesized and their antitumor activities have been tested. A molecular model of the complex between the lead compound and the CDK2 ATP binding site has been built using a combination of ...

Related Articles:

2-Aryl-2-nitroacetates as Central Precursors to Aryl Nitromethanes, α-Ketoesters, and α-Amino Acids

[Metz, Alison E.; Kozlowski, Marisa C. Journal of Organic Chemistry, 2013 , vol. 78, # 2 p. 717 - 722]

… –activity relationships of 1, 3-diaryl 1, 2, 4-(4H)-triazol-5-ones: a new class of calcium-dependent, large conductance, potassium (maxi-K) channel opener targeted for …

[Hewawasam, Piyasena; Erway, Matthew; Thalody, George; Weiner, Harvey; Boissard, Christopher G.; Gribkoff, Valentin K.; Meanwell, Nicholas A.; Lodge, Nicholas; Starrett, Jr, John E. Bioorganic and Medicinal Chemistry Letters, 2002 , vol. 12, # 7 p. 1117 - 1120]

More Articles...